Albany,NY (PRWEB) February 10, 2014
Global Transcatheter Aortic Valve Replacement (TAVR) Market Report: 2013 Edition
The Transcatheter Aortic Valve Replacement (TAVR) is a relatively new technology in medical science which is a less invasive method of replacing the heart valve without undergoing the conventional by-pass surgery. Traditionally, the aortic valve replacement has required open heart surgery, thus disqualifying patients who are at high risk for the process or are too weak to undergo a surgery. Partially for this reason, the market of heart valve surgical procedure is witnessing a continuous decline as more and more patients requiring valve replacement are at high risk for a surgical treatment. This shortcoming of traditional surgery has paved the way for growth of TAVR. It was first commercially launched in Europe in 2007 and later in the United States. The market is very promising and has lot of opportunities and unmet demand to cater to.
To Read Complete Report with TOC: http://www.marketresearchreports.biz/analysis-details/global-transcatheter-aortic-valve-replacement-tavr-market-report-2013-edition
Economic growth worldwide, rising income and wealth levels, increasing ageing population and continuously increasing obese population are fueling the development of the global TAVR market. The growth of the TAVR market has high correlation with macro indicators, such as global GDP, and global healthcare expenditure.
This report analyzes the development of the "global TAVR market", with focus on some of the major markets like the United States and Europe. The major trends, drivers facilitating growth of the TAVR market as well as the issues being faced by the industry are being presented in this report. The major players in the TAVR industry including Edward Lifesciences, Medtronic and St. Jude Medical have been profiled in the report highlighting their key financials and strategies for growth.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables affecting this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis/187023
Table of Content
1. Market Overview
2. TAVR Market Size
4. Competitive Landscape
5. Company Profiles
5.1 Edwards Lifesciences
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
TAVR Product Approval Timeline
TAVR Competitive Landscape
Dependent & Independent Variables (2008– 2012)
Model Summary – Coefficient of Determination
Regression Coefficients Output
To Get Download Sample Report with TOC: http://www.marketresearchreports.biz/analysis/187023
Global Transcatheter Aortic Valve Replacement (TAVR) Procedure
Global TAVR Market by Value (2008-2012)
Global Treatment of Aortic Stenosis (2011 vs. 2020E)
Global Transcatheter Aortic Valve Replacement (TAVR) Procedures (2010-2013E)
Global Transcatheter Aortic Valve Replacement (TAVR) Market Share, By Region (2012)
The US TAVR Market and Penetration Estimates (2011-2015E)
The US TAVR Procedures (2011-2015E)
The US TAVR Procedures - Transapical vs. Transfemoral (2011-2015E)
TAVR Centers in the US (2011-2015E)
Average Selling Prices of TAVR in the US (2011-2015E)
Europe/ROW TAVR Market Size (2010-2015E)
Aortic Valve Replacements in Europe (2012)
European TAVR Procedures (2010-2015E)
Growth of Global Aging Population (60 years and above), (2008-2013E)
World GDP (2005-2012)
Global Healthcare Expenditure (2008-2013E)
Global Obese Population (2004-2012E)
TAVR Market Share by Major Players (2012)
Global TAVR Market Share (2010-2015E)
The US TAVR Market Share by Major Players (2012)
European TAVR Market Share by Major Players (2012)
Edward’s Lifesciences Net Sales by Product Line (2012)
Edward’s Lifesciences Net Sales by Region (2012)
Edward’s Lifesciences Total Sales & Net Income (2008-2012)
Global Sales of Edwards Lifesciences TAVR Procedure (2010-2012)
Medtronic Sales by Product Categories (2012)
Medtronic’s Total Net Revenue and Net Income (2009-2013)
Global Sales of Medtronic TAVR Procedure (2010-2012)
St. Jude Medical Sales by Product Categories (2012)
St. Jude Medical’s Net Sales (2008-2012)
Transcatheter Aortic Valve Replacement Market Forecast (2010-2016)
Building and Construction Plastics Market (PVC, PS, Acrylics, PU, TPE, Composite Materials and Others) For Pipes & Ducts, Insulation, Door Fittingsand Other Applications: Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
The report covers forecast and analysis for the building & construction plastics market on a global and regional level. The study provides historical data of 2012 along with a forecast from 2013 to 2019 based on both volumes (kilo tons) and revenue (USD million). The study includes drivers and restraints for the building & construction plastics market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the building & construction plastics market on a global and regional level.
In order to give the users of this report a comprehensive view on the building & construction plastics Market, we have included a detailed value chain analysis. To understand the competitive landscape in the market, an analysis of Porter’s Five Forces model for the building & construction plastics market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate, general attractiveness and company market share.
The study provides a decisive view on the building & construction plastics market by segmenting the market based on product types and applications. All the product and application segments have been analyzed based on present and future trends and the CAGR for the market is estimated between2013 and2019. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific and Rest of the World (RoW). This segmentation includes demand for individual applications in all the regions.
To Download Sample : http://www.marketresearchreports.biz/sample/sample/186977
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BASF SE, Borealis AG, DuPont, The Dow Chemical Company, Solvay SA, Arkema SA and PetroChina Ltd. among others. Company profiles include attributes such as company overview, financial overview, business strategy, SWOT analysis and recent developments. The market has been segmented as below:
Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests and Others)- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests.
The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician’s offices.
To Download Sample : http://www.marketresearchreports.biz/sample/sample/186981
On the basis of geography, the market is classified into North America, Europe, Asia-Pacific, Africa, Latin America and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the endocrine testing market and future opportunities are provided in the report. A PESTLE analysis has also been considered while estimating the market for individual geographies in order to provide current as well as future status. Several other analytical perspectives such as Porter’s Five Forces Analysis, market share analysis and market attractiveness have been described in the report in order to give a thorough analysis of the market. Also, a list of recommendations for existing as well as new entrants has also been discussed in the study which would help in decision making.
Office: United States
90 State Street, Suite 700
Albany, NY 12207